N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide

We are N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide CAS:3056-33-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide
CAS.NO:3056-33-5
Synonyms:N-(9-Acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide
9,N2-diacetylguanine
2-Acetamido-9-acetyl-6-oxopurine
N2,9-Diacetylguanine
Molecular Formula:C9H9N5O3
Molecular Weight:235.19900
 
Physical and Chemical Properties:
Density:1.67
Melting point:285ºC
Index of Refraction:1.752
 
Specification:
Appearance:Off-white to light brown powder
Assay(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Acyclovir intermediate

N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide


Related News: Inceptua has global operations with local offices across Europe, USA, and AsiaL-leucina CAS:61-90-5 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.4-Dibenzothienylboronic acid Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.2-(3,4-Dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate CAS:164861-52-3 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.

Related Products
Product Name
2-(2-Chloroethoxy)ethanol View Details
6-hydroxynicotinic acid View Details
1-(4-Methoxyphenyl)piperazine Dihydrochloride View Details
[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol manufacturer L-alanyl-L-alanine manufacturer [dimethylamino-(2,3,4,5,6-pentafluorophenoxy)methylidene]-dimethylazanium,hexafluorophosphate manufacturer 2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxylic acid manufacturer 1-(bromomethyl)-4-fluoro-2-(trifluoromethyl)benzene manufacturer